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Acute and EongTerm Bela-Adrenergic 
Bfochde for lwerrats with 
~~~~a~jo~~~j~ syncope 
We cr$yd the study hy Cox ct al, (1) on betaFdrenergic blockade 
therapy fx ne~urocardiogcnic syncope. This study attempted to show 
that patients; who presented with syncopr and near syncopt: had 
significantly fewer episodes of recurrent syncope and near syncope in 
12 months of follow-up if the baseline Lhnormal tilt tahlr study result 
normalixd on a repeat study usmg beta-bl&cr therapy. We had 
severa c+mcerns with the study: 
Tlr first ctrnccrn was the tilt tahlc proton)4 used. hforc spxifieally, 
wc wmdeted whether the investigators had asscsscd what their ft!lse 
p0siitivB rate c)f till studies was in normal subjects, given the r&tivC4~ 
short (ii) min) bwrline study folloucd by an :rgrcssive isoprotcrcnol 
infusinn protowi. This is imprunt bcxause isnprokrunol has been 
:issrX:ialcd with an increaod t&c positive ralt: (2). Secctnd was the: 
atrsencc of a pla~cbo arm. which we think was rthica4 in view of the 
benign prognosis that these patients have. This issue has obvious 
rlinical impiications regarding the need fi?r long-term therapy. Third. 
the inclusion of patients with near qncope was yuestionablc becaux it 
was ncvcr defined and may repre.sent a “soft” end point that would he 
dif4icdlt to measure. it would be interesting to see whether therapy still 
;q+;rrcd tn crntr some clinical benefit if only patients with recurrent 
sy~rcope were analyzed and unly recurrences d syncopo #were accept- 
at& end points. The stated benefit of therapy for this scenario would 
he unlikci; because 39.8% of patients had either near syncop~ or one 
cpisodc of sytxt~p~. Finally, the duration of foftclw-up relative to ~hc 
rrreqticncy of ieported cpisudes appzarcd truncated. More specifically, 
a D-month foliow-up period would be inadequate in many of these 
patients because their event rate was not stated to be at least two 
episode@ar without therapy. If most of the patients had episodes of 
yncqx years alrart, a IOII~IX follow-up period would br needed, and 
the :Ihilily to prove drug c%c:q wcxdd hc problematic, 
In sutnmiu’y. although we think that C~X et al. (I) had a clinically 
rcluvant hypothesis to test, the study design flaws noted hex make the 
stildy rwdts and conclusions difiisult to xccpt. 
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Ic :;~NISC IO the comments aud questions S$ V&h and IIcAutonio, 
WC did not estimate the hlsc: positive rate in normal subjects with our 
pr?Xcxol. I$we~er, we followed the protocol of Almquist et al. (I), 
<which revetiicd tin 11% false positive rate. The mean age of their 
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t3nt “extreme’” left ventricutar dihtion, surgical repkfccarcnt of the 
v&c is not uecrssari!v contraindicated bec21use the increased diastolic 
dimension is not in itself a marker of irreversible ventricuiar dysfunc- 
tion. In multivariate analysis, preoperative left rentticcfai ejection 
fraction was the only significant predictor of postoperati\r ventricular 
functiort, and d&ok ~-hapd3rt &mrnsion, ad ni~‘asureJ by M-mode 
~eb(~~~rdio~ra~by~ was not predbivc. 
Although i l has been sug&ested by others (2) that surgical treat- 
ment for aortic insu&.%q may be recommended on the basis of 
preoperative chamber size without adjustment for body surface area, 
can the present investigators truly support the use of two-dimensional 
chember diameter to predict outcome from a study of only 31 patients 
without acknowledging the subjects’ size? It is possiiiie that the 
subjects were of large enough body habitus to male the two- 
dimensional diameter measurement relatively ie~s significant. ?I& 
reason that the study group included only men was quite likely also 
Wlittd to body ‘iizc. BC:clusC women in general hdvc smaller vcntridcs 
than men, they would be unlikely to develop ;m end-diastolic chamber 
size :2X0 mm. In women (or for that matt::r. any person of small 
stature) “rfxtremc” kft vcntrieular dibtion might OGEUC at a diastolic 
dimension of 70 mm, for example. Ejection phase indexes are predir- 
tive of outcome and postoperative ventricular function because they 
are independent of body SUE. 
It would be very intcresring to lock at the end-diastolic voknnc 
index as a variable in this study to se whcthcr it has any predictive 
vahie. 
We appreciate M&r’s inlerest in our recent article (1). He raises 
important points regarding the management of aortic regurgitation: 
1. The ratioaule for including extreme lrft vc&icuIar diiatios as 
an hidicarion for oywration in patients with %wverc aortic regurgitation 
is based on the ohservatio~r cd’ o~e~rr~nce of sudden death trcuted 
medic&with this extreme ieft vcntricuular dilation (2,3). However. the 
pibstopetative outcome of these patients was poorly d&cd. As 
nrentioncd in out report, the m111~ber of I);ttientb menlioncd in 
ptlblished reports with pt’~opL’tativL” ctifrenv ieft ventricular dil:ltion 
and li&w~d up postoperatively is viny limited! and their outcome was 
usually dtiscrib~d as dismal but was not formally analyzed. Our study 
(1) IN this gap of knowledge by demonstrating that the postoperative 
outcome of these patients with extrcmc left ventricular dilation is 
accsptable,‘although mild excess late mormlity is obhervcd due 10 
associated left mltriculur”dysfuoch”on. 
lndced “only’” 31 patients had ,extreme left ventriculzas di&ian 
bqsd on ad end*diastoolic diaqeter +J mm. Howevqr, this degree of 
‘M vent&&r enl&ement is unusual, and thenceseiit series is, 
knowledge. the largest published. We concur that patients with this 
degrre of left vcotric&tr dilation deserve operation without delay, 
2. A very important issue is the problem of the potential bias 
introdurcd by using left ventricular diameters unadjusted for body size, 
WC certainl_v agree that using unadjtisted diameters is a problem, 
particularlytox women. We have presented in abstract form (4) a,study 
thar is in the process of publication rttgarding aortic regurgitation in 
women. Rrietly, it shows, as Miller may have suspected, that utilization 
of unadjusted left ventricular diameters as surgical criteria, either, 
55 mm at end-sgstole or 80 mm at enddiastole. is irrelevant in women 
with aortic regurgitation because they almost never reach this extent of 
ventricular dilation. This has important consequences for the outcome 
of women with aortic regurgitation, 
3. End~diastolic voh~rnr index was not mca6ured. but diameters 
normalired lo body s&cc area habe no bctrcr prognostic vaIuc than 
ntxrmormalized diameters. ‘Therefore, we cannot spt’citicaliv recom- 
mend using the body surface area-adjusted I&i ventricular diameters 
for the timing of operation. The ejection ph& indexes are predictive 
of the outcome, not only because they are dimensionless, but mosrly 
b~causc they ref!cct the reduced myocardial contractility. 
4. We think that the good outcOme after operation ohsetvsd in 
patients operated on early in the course of their diseavz, as dcnron- 
stratcd in our study (,I). should iead to the re:assessmert UC tlri: optimal 
timing of operation in patiNs with severe aoftic rcpurgitation. ln 
particular, in light of the poor suwivaI of the patients operated on with 
New York Heart A&so&ion class III or IV symptoms (5), even milir 
dyspnca or angina should le;:d to the consideration of operation. 
